Relay Therapeutics, Inc. RLAY Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $204.59M+144% | $84.02M-8.2% | $91.56M-19.6% | $113.94M+21.8% | $93.54M-24.7% | ||
| $658.46M+13.9% | $578.28M-7.3% | $624.01M-8.3% | $680.39M-8.0% | $739.66M-8.6% | ||
| $1.22M-29.2% | $1.73M-26.8% | $2.36M-31.8% | $3.46M-32.8% | $5.15M-12.9% | ||
| $437.48M-7.0% | $470.5M-6.8% | $504.87M-7.0% | $542.83M-12.0% | $616.81M-6.1% | ||
| $699.61M+12.6% | $621.33M-7.3% | $670M-8.1% | $728.84M-8.8% | $799.36M-8.3% | ||
| $29.75M+16.3% | $25.58M-21.6% | $32.61M+0.2% | $32.53M-12.2% | $37.05M-27.0% | ||
| $57.43M+5.8% | $54.27M-12.9% | $62.29M-1.4% | $63.18M-19.3% | $78.28M-16.3% | ||
| $182K+8.3% | $168K0.0% | $168K0.0% | $168K0.0% | $168K0.0% | ||
| -$2.09B-3.6% | -$2.01B-2.8% | -$1.96B-3.9% | -$1.89B-3.9% | -$1.82B-4.4% | ||
| $642.18M+13.2% | $567.06M-6.7% | $607.71M-8.7% | $665.66M-7.7% | $721.08M-7.3% | ||
| $699.61M+12.6% | $621.33M-7.3% | $670M-8.1% | $728.84M-8.8% | $799.36M-8.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Relay Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 22.13 — current assets exceed current liabilities.
- Where does Relay Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.